The Heart of the Matter: Optimizing Launch for Cardiovascular Drugs

Heart disease is a leading cause of death globally, yet the journey to market for new medicines and devices in this therapeutic area is becoming more complex. High development costs, increased scrutiny by regulators and payers, and hurdles to market access are just a few of the challenges you will face, but with the right resources you can streamline the launch process and demonstrate value for your products clinically and commercially.

Tap into an extended network of cardiovascular experts and research solutions

  • Access to a global team of cardiovascular specialists who advise you at every step pre-and-post launch
  • Guidance to achieve scientific differentiation and fulfill regulatory requirements
  • Data and analytics tools to help you identify and assess market opportunities
  • Global patient reported outcomes data on more than 165 conditions
  • Brand/promotional assessment and support for long-term commercial effectiveness